5th Masterclass in Oncology Nursing
Not eligible for ESCO credits
17.03.2012 - 22.03.2012
Ermatingen, Switzerland
MASTERCLASS
Description
Chairs: A. Margulies, CH - S. Faithfull, UK
Scientific Coordinators: L. Sharp, SE
The Masterclass in Oncology Nursing programme is designed for advanced oncology nurses as a multi-professional joint event. Five intensive days of full immersion in up-to-date oncology will create a collective spirit of teaching and learning to improving clinical skills and patient care.
Nursing sessions are specific nursing-oriented sessions exploring specialist practice skills such as advanced assessment, decision making, communication skills, complex symptom management, care of the older patient, psychosocial consequences of cancer therapy.
Other sessions will provide the forum for reviewing and understanding the growing evidence base for nursing interventions and reflect on participant’s role in clinical leadership.
In joint Clinical sessions, nurses will, together with physicians, update their clinical knowledge about the latest issues for the management of various cancers, with an international faculty of experts.
Special joint sessions in symptom management, supportive care and palliative care will be supported by workshops and coaching to explore nursing practice in these speciality areas.
Practical training will be offered in smaller group optional sessions and coaching groups focusing on skills required for the management of active therapy and follow up.
AIMS AND OBJECTIVES
The Masterclass aims to prepare oncology nurses for future senior roles and enhance their clinical knowledge in the management of the cancer patient during all phases of the cancer journey. Following completion of the course nurses will be able to use evidence based knowledge in effective symptom management and interventions with the aim to improve patient experience, symptom management and care.
Learning outcomes:
• Understand new developments in oncology disease management.
• Recognise and describe acute and late adverse effects of cancer and its treatment.
• Identify complex patient needs across the diagnostic and oncology treatment trajectory.
• Demonstrate advanced communication skills in managing oncology nursing care.
• Critically appraise the evidence for cancer symptom management and intervention.
• Reflect on theoretical underpinnings of decision making .
• Describe the role of the advanced oncology nurse in leading clinical nursing care.
TEACHING FORMAT
The Masterclass offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines and which will include notes and resources. Participants will be coached within small groups and discuss personal development plans with tutors in the faculty. Skills based clinical sessions will include simulation and role play and participants must be prepared to join in.
All participants will reside at the course venue and participation in the nursing sessions is compulsory throughout the course.
The Masterclass will be entirely in English and fluency in English is necessary for admission.
Participants of the Masterclass in Nursing Oncology will attend selected medical sessions whilst the advanced communication skills will be attended only by nurses.
Clinical case studies, submitted prior to the course, will be a requirement for all participants. The faculty will evaluate which case studies will be presented for group discussion.
THE MASTERCLASS IS:
• A 5-day residential educational event
• Full immersion
• Clinically-oriented
• Multidisciplinary
• An international faculty of top experts delivering advanced concept
General information
ORGANISING SECRETARIAT
For further information:
eons.secretariat@cancernurse.eu
European Oncology Nursing Society, EONS Secretariat
Att. Rudi Brike
E. Mounierlaan 83
1200 Brussels, Belgium
Phone +32 2 779 9923, Fax +32 2 779 9937
Faculty list
FACULTY (as of Juanuary 2012)
A. Albini, IRCCS MultiMedica, Milan, IT
A. Arber, Faculty of Health and Medical Sciences, University of Surrey, Guilford, UK
J. Bernier, Genolier Swiss Medical Network, Department of Radiotherapy, Genolier, CH
T. Brodowicz, AKH Wien, Vienna, AT
G. Cavaletti, Bicocca University, Department of Neuroscience and Biomedical Technologies, Milan, IT
G. Curigliano, European Institute of Oncology, Div. of Medical Oncology, Milan, IT
A. Dietz, University of Leipzig, Department of Otolaryngology, Leipzig, DE
S. Faithfull, Faculty of Health and Medical Sciences, University of Surrey, Guilford, UK
C. Faivre-Finn, Christie Hospital NHS Foundation Trust, Department of Clinical Oncology, Manchester, UK
W. Gatzemeier, Humanitas Clinical Institute, Breast Unit, Rozzano, IT
M. Ghielmini, Oncology Institute of Southern Switzerland, Division of Medical Oncology, Bellinzona, CH
A. Hoy, Consultant in Palliative Medicine, Lead for Advanced Communication Skills SWSH, Epsom, UK
K.H. Köhne, Klinikum Oldenburg, Klinik für Onkologie und Hämatologie, Oldenburg, DE
A. Margulies, Clinical Oncology Nurse, EONS Executive Board Member, Zurich, CH
O. Pagani, Oncology Institute of Southern Switzerland (IOSI), Department
N. Pavlidis, University of Ioannina, Division of Medical Oncology, Ioannina, GR
G.J. Poston, Aintree University Hospital, Dept. of Surgery, Liverpool, UK
G. Pruneri, European Institute of Oncology, Department of Pathology, and Milan University, Milan, IT
K. Redmond, Cancer World Magazine, Lugano, CH
D. Schrijvers, Ziekenhuisnetwerk Antwerpen-Middelheim, Department of
Haemato-Oncology, Antwerp, BE
S. Segaert, University Hospital Sint-Rafaël, Dermatology Department, Leuven, BE
C. Sessa, Oncology Institute of Southern Switzerland, Division of Medical Oncology, Bellinzona, CH
L. Sharp, Karolinska University Hospital, Section for Nursing, Stockholm, SE
R.A. Stahel, University Hospital Zurich, Clinic and Policlinic for Oncology, Zurich, CH
E. Van Cutsem, University Hospital Gasthuisberg, Digestive Oncology Unit, Leuven, BE
J.B. Vermorken, University Hospital Antwerp, Department of Oncology, Edegem, BE
W. Weder, University Hospital Zurich, Division of Thoracic Surgery, Zurich, CH
E. Von Muilekom, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital,
Amsterdam, NL
M. Wells, University of Dundee, Dundee, UK
Programme
17 March
Participants' arrival, airport transfers, registration | |
14:30 | Greetings and introduction to Masterclass in Oncology Nursing: Aims and objectives A. Margulies, CH - S. Faithfull, UK |
15:00 | Group introduction |
15:30 | Role development: Advanced oncology nursing practice |
16:15 | Developing the evidence base for oncology nursing practice |
17:00 | Overview of Therapy modalities and new developments in the treatment of prostate cancer E. Van Muilekom, NL |
17:50 | Coffee break |
18:20 | Coaching: two groups A. Margulies, CH - S. Faithfull, UK - L. Sharp, SE - E. Van Muilekom, NL |
20:30 | Dinner |
18 March
8:30 | Clinical session Breast cancer I |
| |
10:45 | Coffee break |
11:15 | New development in radiotherapy |
12:00 | "Targeted" therapy - an introduction |
12:15 | Case studies presentation and discussion + plenary presentation |
13:15 | Lunch |
14:30 | Spotlight session 1 Haematological diseases |
15:30 | Introduction to communication skills; Assessiong psychosocial health A. Hoy, UK - A. Arber, UK |
16:30 | Coffee break |
17:00 | Communication skills cont. A. Hoy, UK - A. Arber, UK |
19:30 | Dinner |
19 March
8:30 | Communication skills workshop – Group 1 A. Hoy, UK - A. Arber, UK |
8:30 | Clinical session Gynaecological cancers |
|
|
10:30 | Coffee break |
11:00 | Communication skills workshop - Group 2 A. Hoy, UK - A. Arber, UK |
11:00 | Clinical session Head and neck cancer |
|
|
13:00 | Lunch |
14:30 | Advanced Nursing Assessment skills |
15:30 | Research in clinical nursing |
16:30 | Spotlight session 3 Cancer and pregnancy N. Pavlidis, GR |
17:00 | Coffee break |
17:30 | 10 min review gynaecology - Hand and neck sessions |
19:30 | Dinner |
20 March
8:30 | Clinical session Gastro-intestinal tumours I |
Colon cancer:
| |
10:00 | Sponsored lecture Metastasectomies in colorectal cancer (SPCC lecture by Merk) G.J. Poston, UK |
10:30 | Coffee break |
11:00 | Market place Sharpening your symptom management expertise |
| |
13:30 | Lunch |
14:30 | Sponsored lecture Maintenance treatment in advanced non small cell lung cancer: a new treatment paradigm? (SPCC lecture by Lilly) T. Brodowicz, AT |
15:00 | e-Eso session on New accomplishments in breast cancer chemoprevention A. Decensi, Galliera Hospital, Genoa, IT |
16:00 | Free afternoon |
19:30 | Dinner |
21 March
8:30 | Clinical session Lung cancer and mesothelioma I |
|
|
10:30 | Coffee break |
11:00 | Clinical session Lung cancer and mesothelioma II |
|
|
12:00 | Case study presentation and discussions + plenary presentation |
13:00 | Lunch |
14:15 | Joint medics and nursing session Side effects of systemic treatment and their management |
15:15 |
|
15:30 | Joint medics and nursing session Oral therapy: Adherence, compliance and drug interaction K. Redmond, CH |
16:00 | Coffee break |
16:30 | Joint medics and nursing session Palliative care |
| |
18:00 | Learning assessment tests |
19:30 | Dinner |
22 March
8:30 | Survivorship and long term care planning |
9:30 | Developing your clinical practice “Pictures speak louder than words” |
10:30 | Coffee break |
11:00 | Presentation of results / Coaching Session Participants |
12:00 | Closure |